PH15152A - Crystalline 3-hydroxy-cephalosporin solvates - Google Patents

Crystalline 3-hydroxy-cephalosporin solvates

Info

Publication number
PH15152A
PH15152A PH23579A PH23579A PH15152A PH 15152 A PH15152 A PH 15152A PH 23579 A PH23579 A PH 23579A PH 23579 A PH23579 A PH 23579A PH 15152 A PH15152 A PH 15152A
Authority
PH
Philippines
Prior art keywords
crystalline
hydroxy
cephalosporin
solvates
cephalosporin solvates
Prior art date
Application number
PH23579A
Other languages
English (en)
Inventor
Jack Wayne Fisher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH15152A publication Critical patent/PH15152A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/30Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino-radical acylated by an araliphatic carboxylic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH23579A 1979-02-01 1980-02-01 Crystalline 3-hydroxy-cephalosporin solvates PH15152A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US846879A 1979-02-01 1979-02-01

Publications (1)

Publication Number Publication Date
PH15152A true PH15152A (en) 1982-08-24

Family

ID=21731772

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23579A PH15152A (en) 1979-02-01 1980-02-01 Crystalline 3-hydroxy-cephalosporin solvates

Country Status (32)

Country Link
EP (1) EP0014565B1 (OSRAM)
JP (1) JPS55104288A (OSRAM)
KR (1) KR830001890B1 (OSRAM)
AR (1) AR228342A1 (OSRAM)
AT (1) AT366052B (OSRAM)
AU (1) AU532573B2 (OSRAM)
BE (1) BE881423A (OSRAM)
BG (1) BG32857A3 (OSRAM)
CA (1) CA1142173A (OSRAM)
CH (1) CH647525A5 (OSRAM)
CS (1) CS214694B2 (OSRAM)
DD (1) DD148953A5 (OSRAM)
DE (1) DE3062095D1 (OSRAM)
DK (1) DK159157C (OSRAM)
ES (1) ES488229A0 (OSRAM)
FI (1) FI68239C (OSRAM)
FR (1) FR2447925A1 (OSRAM)
GB (1) GB2041934B (OSRAM)
GR (1) GR72785B (OSRAM)
HU (2) HU181761B (OSRAM)
IE (1) IE49374B1 (OSRAM)
IL (1) IL59265A (OSRAM)
IT (1) IT1130239B (OSRAM)
LU (1) LU82118A1 (OSRAM)
NZ (1) NZ192750A (OSRAM)
PH (1) PH15152A (OSRAM)
PL (1) PL122609B1 (OSRAM)
PT (1) PT70742A (OSRAM)
RO (2) RO79181A (OSRAM)
SU (2) SU897109A3 (OSRAM)
YU (1) YU22480A (OSRAM)
ZA (1) ZA80523B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128949A1 (de) * 1981-07-22 1983-02-10 Basf Ag, 6700 Ludwigshafen Lichtempfindliche aufzeichnungsmaterialien zur herstellung von abriebs- und kratzfesten tiefdruckformen sowie verfahren zur herstellung von tiefdruckformen mittels dieser aufzeichnungsmaterialien
JPS6011491A (ja) * 1983-03-04 1985-01-21 Shionogi & Co Ltd セフアロチンナトリウムの結晶性凍結乾燥粉末の製造法
US4782144A (en) * 1987-09-14 1988-11-01 Eli Lilly And Company 1-carba(dethia)-3-hydroxy-3-cephem ester crystalline and crystalline solvate thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
US4044002A (en) * 1976-06-09 1977-08-23 Eli Lilly And Company Reduction process for cephalosporin sulfoxides

Also Published As

Publication number Publication date
AU532573B2 (en) 1983-10-06
GR72785B (OSRAM) 1983-12-05
IE49374B1 (en) 1985-09-18
DK159157C (da) 1991-02-11
DD148953A5 (de) 1981-06-17
PL122609B1 (en) 1982-08-31
ES8103098A1 (es) 1981-02-16
IE800191L (en) 1980-08-01
RO83702A (ro) 1984-03-15
NZ192750A (en) 1982-05-25
ES488229A0 (es) 1981-02-16
PL221748A1 (OSRAM) 1980-12-15
AU5502680A (en) 1980-08-07
FR2447925A1 (fr) 1980-08-29
CA1142173A (en) 1983-03-01
JPH0128035B2 (OSRAM) 1989-05-31
CS214694B2 (en) 1982-05-28
DK159157B (da) 1990-09-10
ATA49980A (de) 1981-07-15
RO83702B (ro) 1984-03-30
IL59265A (en) 1983-05-15
IT8019607A0 (it) 1980-01-31
RO79181A (ro) 1982-06-25
DK41180A (da) 1980-08-02
LU82118A1 (fr) 1980-04-23
EP0014565A1 (en) 1980-08-20
FI68239B (fi) 1985-04-30
KR830001951A (ko) 1983-05-21
BE881423A (fr) 1980-07-30
GB2041934B (en) 1983-03-23
EP0014565B1 (en) 1983-02-23
KR830001890B1 (ko) 1983-09-17
JPS55104288A (en) 1980-08-09
SU897109A3 (ru) 1982-01-07
ZA80523B (en) 1981-09-30
AR228342A1 (es) 1983-02-28
FI800300A7 (fi) 1980-08-02
IL59265A0 (en) 1980-05-30
SU938740A3 (ru) 1982-06-23
GB2041934A (en) 1980-09-17
AT366052B (de) 1982-03-10
YU22480A (en) 1983-02-28
HU181761B (en) 1983-11-28
PT70742A (en) 1980-02-01
HU182095B (en) 1983-12-28
DE3062095D1 (en) 1983-03-31
CH647525A5 (fr) 1985-01-31
IT1130239B (it) 1986-06-11
BG32857A3 (bg) 1982-10-15
FR2447925B1 (OSRAM) 1984-02-03
FI68239C (fi) 1985-08-12

Similar Documents

Publication Publication Date Title
EP0021287A3 (en) Multi-microprocessorsystem
GB2060504B (en) Twin-hull watercaft
GB2067748B (en) Retroreflectometer
JPS55133345A (en) Mercaptoacyldipeptides
JPS55136601A (en) Wheellhub cappassembly
GB2064195B (en) Bodyforms
JPS55145691A (en) 77nnheterocycrylcephalosporin
GB2052178B (en) Lampsockets
GB2066407B (en) Pig-trap
JPS5697297A (en) Crystalline 4*1**6**trichloroo4*1**6** trideoxygalactose
PH15152A (en) Crystalline 3-hydroxy-cephalosporin solvates
JPS55143992A (en) Crystallization
JPS55147283A (en) Spirooquinolonehydantoins
JPS55112201A (en) Emarzans
GB2121032B (en) Cyanopiperidinobutyrophenones
JPS55122782A (en) Pyrimidoo22benzazepines
JPS55120702A (en) Ridger
GB2059953B (en) 3-aryl-3-aryloxyalkylamines
NZ194686A (en) Substituted 2-carbamoyloxyimino-butanes
JPS56120703A (en) Improvement
IL61348A0 (en) (-)-alpha-cyano-m-phenoxybenzyl(+)-alphaisopropyl-4-difluoromethoxy-phenylacetate
CA44955S (en) Citruspress
GB2043503B (en) Sraightening
GB2044761B (en) 6-chloro- 6 - deoxy - d - hexitols
GB2060878B (en) Explosimeter

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14